home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

The next wave of disease diagnosis - proteomics

  October, 22 2002 3:00
your information resource in human molecular genetics
Protein patterns in blood may help dianose prostate cancer

Patterns of proteins found in patients' blood serum may help distinguish between prostate cancer and benign conditions, scientists from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA) report in the "Journal of the National Cancer Institute". The new proteomic approach which requires a drop of blood and just 30 minutes has a high specificity in deciding whether to perform a biopsy in men with elevated prostate specific antigen (PSA) levels. Using this technique, researchers were able to differentiate between samples taken from patients diagnosed with cancer and those from patients diagnosed with benign prostate disease.
Although the technique is still under evaluation, it is believed that this can serve as a powerful tool in the diagnosis of other cancers as well.

Jennifer Michalowski
National Cancer Institute Press Office
(301) 496-6641

Message posted by: Rashmi Nemade

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.